Successful investing is about anticipating others' anticipation. The value of a stock is based on what people think it's worth. Selling shares of Hyperfine may be a great opportunity for buyers. One ...

For the full year 2026, Hyperfine expects revenue between $20 million to $22 million, representing year-over-year growth at the midpoint of 55%. Gross margin for 2026 is forecast in the range of 50% ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® ...

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality This major Swoop® system scanner redesign and ...

CE approval of the latest generation Swoop ® system software is a significant milestone in Hyperfine’s international strategy, allowing broader European commercial expansion. GUILFORD, ...

GUILFORD, Conn. - Hyperfine, Inc. (NASDAQ:HYPR), a pioneering health technology firm with a current market capitalization of ...